#GLP1 #Ozempic #WeightLossStall #ObesityMedicine #FatLoss
GLP-1 medications like Ozempic, Wegovy, and Zepbound are powerful tools for weight loss — but they don’t work the same for everyone.
Some patients lose significant weight… while others plateau, lose slowly, or feel like the medication isn’t working at all.
In this video, Dr. Mohammed Paika (board-certified in Internal Medicine & Obesity Medicine) explains the real medical reasons GLP-1 weight loss can stall — including dosing, metabolic adaptation, muscle loss, nutrition, and underlying health factors.
If your weight loss has slowed or stopped on GLP-1 therapy, this video will help you understand why — and what actually improves results.
⏱️ TIMESTAMPS
0:00 Why GLP-1 Doesn’t Work the Same for Everyone
0:42 Expectation vs Reality on GLP-1
1:35 Reason 1 — Dose & Duration
2:45 Reason 2 — Metabolic Adaptation
4:05 Reason 3 — Muscle Loss
5:25 Reason 4 — Ultra-Processed Diet
6:40 Reason 5 — Medical Factors
7:55 True Non-Responders
8:35 What Improves GLP-1 Results
⚕️ MEDICAL & EDUCATIONAL DISCLAIMER
This channel and its content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information presented is not intended as medical advice and does not replace consultation with your personal physician or qualified healthcare professional.
Viewing this content does not create a doctor-patient relationship between you and Dr. Paika.
Health, nutrition, exercise, and medication topics discussed on this channel may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.
Exercise and lifestyle changes carry inherent risks. By choosing to follow any information from this channel, you accept full responsibility for your health decisions and outcomes.
Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from use or application of information presented in this content.